Literature DB >> 8407884

Cell density-dependent regulation of hepatocyte growth factor receptor on adult rat hepatocytes in primary culture.

K Mizuno1, O Higuchi, H Tajima, T Yonemasu, T Nakamura.   

Abstract

The proliferative potential of hepatocytes in the normal intact liver is highly suppressed, but they proliferate actively after liver injury. In this study, adult rat hepatocytes in primary culture were used to study mechanisms controlling hepatocyte growth in liver regeneration. DNA synthesis in hepatocytes cultured at a low cell density was highly stimulated in response to hepatocyte growth factor (HGF), but this stimulatory effect was not so obvious in hepatocytes cultured at a high cell density. In close parallel to the potency of DNA synthesis, the amounts of 125I-HGF specifically bound to hepatocytes cultured at a low cell density were much greater than in high cell density culture. Scatchard plots revealed that change in the specific binding of 125I-HGF was due to change in the number of high-affinity HGF receptors, but without change in the Kd values. Affinity cross-linking of the HGF receptor with 125I-HGF confirmed the higher expression of HGF receptor on hepatocytes cultured at a lower cell density. Since there was no significant change in the expression of c-met mRNA in hepatocytes cultured at different cell densities, the number of cell surface HGF receptors is probably regulated by post-transcriptional mechanisms. We also found that the rates of HGF-induced down-regulation and recovery of HGF receptors on hepatocytes cultured at a low cell density were much faster than in cases of a high cell density.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407884     DOI: 10.1093/oxfordjournals.jbchem.a124147

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

Authors:  M Inui; N Nishi; A Yasumoto; I Takenaka; H Miyanaka; K Matsumoto; T Nakamura; F Wada
Journal:  Urol Res       Date:  1996

2.  C-myc is required for the G0/G1-S transition of primary hepatocytes stimulated with a deleted form of hepatocyte growth factor.

Authors:  G G Skouteris; C H Schröder
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

3.  Expression of hepatocyte growth factor receptor (c-met) mRNA in primary cultures of human hepatocytes.

Authors:  S Hirono; S Afford; A J Strain
Journal:  Clin Mol Pathol       Date:  1995-08

4.  A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.

Authors:  Nobuaki Okumura; Tomohiko Koh; Yuichi Hasebe; Taiichiro Seki; Toyohiko Ariga
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

5.  Transglutaminase induced by epidermal growth factor negatively regulates the growth signal in primary cultured hepatocytes.

Authors:  S Katoh; N Nakagawa; Y Yano; K Satoh; H Kohno; Y Ohkubo
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

6.  Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.

Authors:  Sameer A Greenall; Ermanno Gherardi; Zhanqi Liu; Jacqueline F Donoghue; Angela A Vitali; Qian Li; Roger Murphy; Luisa Iamele; Andrew M Scott; Terrance G Johns
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

7.  Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells.

Authors:  Marina S Dietz; Daniel Haße; Davide M Ferraris; Antonia Göhler; Hartmut H Niemann; Mike Heilemann
Journal:  BMC Biophys       Date:  2013-06-03       Impact factor: 4.778

8.  Three-dimensional culture of hepatocytes in a continuously flowing medium.

Authors:  K Takeshita; W C Bowen; G K Michalopoulos
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.